A multicenter multidimensional study of some new longacting neuroleptic drugs.
D000203:Activities of Daily Living; D000293:Adolescent; D000328:Adult; D000368:Aged; D001291:Attitude of Health Personnel; D002208:Caproates / Q000627:therapeutic use; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D005260:Female; D005476:Fluphenazine / Q000627:therapeutic use*; D006801:Humans; D006993:Hypnotics and Sedatives / Q000627:therapeutic use*; D007400:Interprofessional Relations; D008297:Male; D008875:Middle Aged; D010868:Pimozide / Q000627:therapeutic use*; D011369:Professional-Patient Relations; D011569:Psychiatric Status Rating Scales; D012559:Schizophrenia / Q000188:drug therapy*; D012931:Social Environment; D013141:Spiro Compounds / Q000627:therapeutic use; D014268:Trifluoperazine / Q000627:therapeutic use*
D002208:Caproates; D006993:Hypnotics and Sedatives; D013141:Spiro Compounds; D010868:Pimozide; D014268:Trifluoperazine; D005476:Fluphenazine